Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis
NCT01517282
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
MOR103
OTHER:
Placebo
Sponsor
MorphoSys AG